RT Journal Article
SR Electronic
T1 The effectiveness of telemedicine in the prevention of type 2 diabetes: a systematic review and meta-analysis of interventions
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.04.30.24306650
DO 10.1101/2024.04.30.24306650
A1 Suhlrie, Laura
A1 Ayyagari, Raga
A1 Mba, Camille
A1 Olsson, Kjell
A1 Torres-Aparcana, Harold
A1 James, Steven
A1 Vounzoulaki, Elpida
A1 Ibsen, Daniel B.
YR 2024
UL http://medrxiv.org/content/early/2024/05/01/2024.04.30.24306650.abstract
AB Objective To evaluate the effectiveness of telemedicine-delivered diet and/or exercise interventions to prevent type 2 diabetes (T2D) in people at risk.Methods Embase (via Ovid), Medline (via Ovid), Web of Science, CINAHL, Scopus and SciELO were searched from January 2010-December 2020 for intervention studies using a diet and/or exercise intervention delivered through telemedicine for T2D prevention in people at risk. Parallel randomised controlled trials were meta-analyzed and other intervention designs narratively synthesised.Results We identified 11,645 studies via database searches, of which 226 were full text screened, and 52 interventions included; 32 were included in the meta-analysis and 20 in the narrative synthesis. Telemedicine interventions reduced body weight (mean difference (MD): -1.66 kg, 95% confidence interval (CI) -2.48,-0.90, I2=81%, nstudies=17), body mass index (MD -0.71 kg/m2, 95% CI -1.06,-0.37, I2=70%, nstudies=11), waist circumference (MD -2.82 cm, 95% CI -5.16,-2.35, I2=84%, nstudies=7) and HbA1c (MD -0.07%, 95% CI -0.14,0.00, I2=71%, nstudies=11). No significant effects were found for other clinical outcomes. The narrative synthesis supported the results.Conclusions Our study highlights the potential for telemedicine-delivered interventions in preventing T2D in people at risk.Competing Interest StatementThe authors have declared no competing interest.Clinical Protocols https://www.crd.york.ac.uk/prospero/display_record.php?RecordID=210829 Funding StatementNone.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors